Table 1 Patients' baseline clinical characteristics, infarct features, and treatment according to coronary care unit (CCU) admission.
| Admitted to the CCU | p Value | ||
|---|---|---|---|
| Yes (n = 60) | No (n = 40) | ||
| Age (years) | 90.7 (1.9) | 92.2 (2.2) | <0.001 |
| Infarct features | |||
| Chest pain | 54 (90.0%) | 20 (50.0%) | <0.001 |
| Killip class >I | 17 (28.3%) | 28 (70.0%) | <0.01 |
| Time delay (hours) | 6.3 (7.5) | 14.9 (16.4) | 0.002 |
| LBBB | 5 (8.3%) | 10 (25.0%) | 0.04 |
| LVEF <30% | 22 (39.3%) | 15 (62.5%) | 0.05 |
| Heart failure | 32 (53.3%) | 36 (90.0%) | <0.001 |
| Complete AV block | 6 (10.0%) | 3 (7.5%) | 0.67 |
| Treatment | |||
| β Blockers | 33 (55.0%) | 9 (22.5%) | 0.001 |
| Intravenous nitrates | 36 (60.0%) | 15 (37.5%) | 0.03 |
| GP IIb/IIIa inhibitors | 7(11.7%) | 0 (0%) | 0.08 |
| Diuretics | 30 (50.0%) | 31 (77.5%) | 0.009 |
| Heparin | 47 (78.3%) | 26 (65.0%) | 0.001 |
| Inotropic agents | 13 (21.7%) | 3 (7.5%) | 0.001 |
| Thrombolysis | 9 (15.0%) | 0 (0%) | 0.03 |
AV, atrioventricular; GP, glycoprotein; LBBB, left bundle branch block; LVEF, left ventricular ejection fraction.